These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10659869)
21. Chlorhexidine and silver sulfadiazine coating on central venous catheters is not sufficient for protection against catheter-related infection: Simulation-based laboratory research with clinical validation. Choi YJ; Lim JK; Park JJ; Huh H; Kim DJ; Gong CH; Yoon SZ J Int Med Res; 2017 Jun; 45(3):1042-1053. PubMed ID: 28534703 [TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU. Frank U; Chojnacki T; Dettenkofer M; Daschner FD Intensive Care Med; 2003 Jan; 29(1):139. PubMed ID: 12528036 [No Abstract] [Full Text] [Related]
23. Central venous catheterization: a prospective, randomized, double-blind study. Mer M; Duse AG; Galpin JS; Richards GA Clin Appl Thromb Hemost; 2009 Feb; 15(1):19-26. PubMed ID: 18593746 [TBL] [Abstract][Full Text] [Related]
24. Complications of the ethanol-lock technique in the treatment of central venous catheter sepsis. Laird J; Soutar R; Butcher I J Infect; 2005 Nov; 51(4):338. PubMed ID: 16291289 [No Abstract] [Full Text] [Related]
25. Susceptibility of coagulase-negative staphylococcal nosocomial bloodstream isolates to the chlorhexidine/silver sulfadiazine-impregnated central venous catheter. Rosato AE; Tallent SM; Edmond MB; Bearman GM Am J Infect Control; 2004 Dec; 32(8):486-8. PubMed ID: 15573055 [No Abstract] [Full Text] [Related]
26. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Casey AL; Mermel LA; Nightingale P; Elliott TS Lancet Infect Dis; 2008 Dec; 8(12):763-76. PubMed ID: 19022192 [TBL] [Abstract][Full Text] [Related]
27. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Walz JM; Avelar RL; Longtine KJ; Carter KL; Mermel LA; Heard SO; Crit Care Med; 2010 Nov; 38(11):2095-102. PubMed ID: 20711070 [TBL] [Abstract][Full Text] [Related]
28. Summaries for patients. Antiseptics to prevent infection from intravascular catheters. Ann Intern Med; 2002 Jun; 136(11):I26. PubMed ID: 12044142 [No Abstract] [Full Text] [Related]
29. Catheter-related bloodstream infection. Goede MR; Coopersmith CM Surg Clin North Am; 2009 Apr; 89(2):463-74, ix. PubMed ID: 19281894 [TBL] [Abstract][Full Text] [Related]
30. Are antiseptic-coated central venous catheters effective in a real-world setting? Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109 [TBL] [Abstract][Full Text] [Related]
31. Catheter-associated bloodstream infections in the NICU: getting to zero. Curry S; Honeycutt M; Goins G; Gilliam C Neonatal Netw; 2009; 28(3):151-5. PubMed ID: 19451076 [TBL] [Abstract][Full Text] [Related]
32. Effects of blood flow on the antibacterial efficacy of chlorhexidine and silver sulfadiazine coated central venous catheter: A simulation-based pilot study. Cui YH; Choi YJ; Kim EH; Yu JH; Seong HY; Choi SU; Yoon SZ; Huh H Medicine (Baltimore); 2020 Sep; 99(39):e22218. PubMed ID: 32991414 [TBL] [Abstract][Full Text] [Related]
33. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Montecalvo MA; McKenna D; Yarrish R; Mack L; Maguire G; Haas J; DeLorenzo L; Dellarocco N; Savatteri B; Rosenthal A; Watson A; Spicehandler D; Shi Q; Visintainer P; Wormser GP Am J Med; 2012 May; 125(5):505-11. PubMed ID: 22482848 [TBL] [Abstract][Full Text] [Related]
34. Evidence-based prevention of catheter infection during parenteral nutrition. Attar A; Messing B Curr Opin Clin Nutr Metab Care; 2001 May; 4(3):211-8. PubMed ID: 11517355 [TBL] [Abstract][Full Text] [Related]
35. Anti-microbial or antiseptic impregnated central venous catheters: update on a "central" debate. dos Santos CC; Stewart TE; McGeer A Intensive Care Med; 2000 Feb; 26(2):246-9. PubMed ID: 10784318 [No Abstract] [Full Text] [Related]
36. Reply to letter on our article: Lorente L, Lecuona M, Jiménez A, Raja L, Cabrera J, Gonzalez O, et al. Chlorhexidine-silver sulfadiazine- or rifampicinmiconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly. Am J Infect Control. 2015 Sep 24. pii:S0196-6553(15)00931-1. doi: 10.1016/j.ajic.2015.08.014. Lorente L; Cabrera J; Lorenzo L; Raja L; Santacreu R; Mora ML Am J Infect Control; 2016 Jun; 44(6):731-2. PubMed ID: 26810871 [No Abstract] [Full Text] [Related]
37. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters. Haxhe JJ; D'Hoore W J Hosp Infect; 1998 Oct; 40(2):166-8. PubMed ID: 9819700 [No Abstract] [Full Text] [Related]